BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yin J, Ye YL, Hu T, Xu LJ, Zhang LP, Ji RN, Li P, Chen Q, Zhu JY, Pang Z. Hsa_circRNA_102610 upregulation in Crohn’s disease promotes transforming growth factor-β1-induced epithelial-mesenchymal transition via sponging of hsa-miR-130a-3p. World J Gastroenterol 2020; 26(22): 3034-3055 [PMID: 32587447 DOI: 10.3748/wjg.v26.i22.3034]
URL: https://www.wjgnet.com/1007-9327/full/v26/i22/3034.htm
Number Citing Articles
1
Sarah Stiegeler, Kevin Mercurio, Miruna Alexandra Iancu, Sinéad C. Corr. The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut PermeabilityCells 2021; 10(12): 3358 doi: 10.3390/cells10123358
2
Yu‐an Hu, Yan Zhu, Guorui Liu, Xinyue Yao, Xiaoling Yan, Yang Yang, Weiping Wang, Xiaoping Zou, Xiaojun Li. Expression profiles of circular RNAs in colon biopsies from Crohn's disease patients by microarray analysisJournal of Clinical Laboratory Analysis 2021; 35(6) doi: 10.1002/jcla.23788
3
Xiao Xuan Lin, Yun Qiu, Xiao Jun Zhuang, Fen Liu, Xiao Min Wu, Min Hu Chen, Ren Mao. Intestinal stricture in Crohn's disease: A 2020 updateJournal of Digestive Diseases 2021; 22(7): 390 doi: 10.1111/1751-2980.13022
4
Juan Yin, Fuyi Tong, Yulan Ye, Tong Hu, Lijuan Xu, Liping Zhang, Jianyun Zhu, Zhi Pang. Hsa_circRNA_103124 Upregulation in Crohn’s Disease Promotes Cell Proliferation and Inhibits Autophagy by Regulating the Hsa-miR-650/AKT2 Signaling PathwayFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.753161
5
Long-Yuan Zhou, Si-Nan Lin, Florian Rieder, Min-Hu Chen, Sheng-Hong Zhang, Ren Mao. Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn’s Disease: The Path From Bench to BedsideInflammatory Bowel Diseases 2021; 27(7): 971 doi: 10.1093/ibd/izaa321
6
Yanhong Liu, Yan Ding, Yapeng Hou, Tong Yu, Hongguang Nie, Yong Cui. The miR-130a-3p/TGF-βRII Axis Participates in Inhibiting the Differentiation of Fibroblasts Induced by TGF-β1Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.732540